Raymond James Maintains Outperform on Zimmer Biomet Holdings, Lowers Price Target to $123
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Jayson Bedford maintains an Outperform rating on Zimmer Biomet Holdings (NYSE:ZBH) but lowers the price target from $128 to $123.
October 14, 2024 | 5:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Raymond James has maintained an Outperform rating for Zimmer Biomet Holdings but has lowered the price target from $128 to $123, indicating a slightly less optimistic outlook.
The maintenance of an Outperform rating suggests continued confidence in Zimmer Biomet's performance, but the lowered price target indicates a tempered outlook, which could lead to a slight negative impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100